Endotoxin-induced il-6 promoter activation in skeletal muscle requires an nf-κb site

International Journal of Interferon, Cytokine and Mediator Research

Volumn 2, Issue 1, 2010, Pages 9-21

  Yeagley, David ^a   Lang, Charles H ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

IL 1; Inflammation; Lipopolysaccharide; Myocytes; Promoter activity; TNF

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPRESSION VECTOR; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; IMMUNOMODULATION; INDUCED MUTATION; INNATE IMMUNITY; MOUSE; MUSCLE CELL; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; WESTERN BLOTTING; WILD TYPE;

EID: 77953470385     PISSN: None     EISSN: 1179139X     Source Type: Book Series    
DOI: None     Document Type: Article

References (40)

1. Frost RA, Lang CH. Regulation of muscle growth by pathogen- associated molecules. J Anim Sci. 2008;86:E84-E93.
2. Frost RA, Lang CH. Skeletal muscle cytokines: regulation by pathogen- associated molecules and catabolic hormones. Curr Opin Clin Nutr Metab Care. 2005;8:255-263.
3. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621-636.
4. Ray A, Tatter SB, Santhanam U, et al. Regulation of expression of interleukin-6. Molecular and clinical studies. Ann N Y Acad Sci. 1989;557:353-361.
5. Kishimoto T, Hibi M, Murakami M, et al. The molecular biology of interleukin 6 and its receptor. Ciba Found Symp. 1992;167:5-16.
6. Sehgal PB. Regulation of IL6 gene expression. Res Immunol. 1992;143:724-734.
7. Dendorfer U, Oettgen P, Libermann TA. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol. 1994;14: 4443-4454.
8. Akira S, Isshiki H, Nakajima T, et al. A nuclear factor for the IL-6 gene (NF-IL6). Chem Immunol. 1992;51:299-322.
9. Zhang Y, Lin JX, Vilcek J. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem. 1988;263:6177-6182.
10. Zhang YH, Lin JX, Yip YK, et al. Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. Proc Natl Acad Sci U S A. 1988;85:6802-6805.
11. Frost RA, Nystrom GJ, Lang CH. Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2002;283: R698-R709.
12. Frost RA, Nystrom GJ, Lang CH. Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase. Am J Physiol Regul Integr Comp Physiol. 2003;285:R1153-R1164.
13. Frost RA, Nystrom GJ, Lang CH. Multiple toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes. Am J Physiol Regul Integr Comp Physiol. 2006;290:R773-R784.
14. Eickelberg O, Pansky A, Mussmann R, et al. Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem. 1999;274:12933-12938.
15. Smart DE, Vincent KJ, Arthur MJ, et al. JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J Biol Chem. 2001;276:24414-24421.
16. Xiao G, Cvijic ME, Fong A, et al. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J. 2001;20:6805-6815.
17. Xiao G, Harhaj EW, Sun SC. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell. 2001;7:401-409.
18. Yeagley D, Moll J, Vinson CA, et al. Characterization of elements mediating regulation of phosphoenolpyruvate carboxykinase gene transcription by protein kinase A and insulin. Identification of a distinct complex formed in cells that mediate insulin inhibition. J Biol Chem. 2000;275:17814-17820.
19. Frost RA, Lang CH, Gelato MC. Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulinlike growth factor-I stimulated protein synthesis. Endocrinology. 1997;138:4153-4159.
20. Frost RA, Nystrom GJ, Lang CH. Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway. Endocrinology. 2003;144:1770-1779.
21. Hurst HC, Masson N, Jones NC, et al. The cellular transcription factor CREB corresponds to activating transcription factor 47 (ATF-47) and forms complexes with a group of polypeptides related to ATF-43. Mol Cell Biol. 1990;10:6192-6203.
22. Yeagley D, Agati JM, Quinn PG. A tripartite array of transcription factor binding sites mediates cAMP induction of phosphoenolpyruvate carboxykinase gene transcription and its inhibition by insulin. J Biol Chem. 1998;273:18743-18750.
23. Qu Z, Qing G, Rabson A, et al. Tax deregulation of NF-kappaB2 p100 processing involves both beta-TrCP-dependent and -independent mechanisms. J Biol Chem. 2004;279:44563-44572.
24. Akiba H, Nakano H, Nishinaka S, et al. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem. 1998;273:13353-13358.
25. Holtmann H, Winzen R, Holland P, et al. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokineor stress-activated signal transduction pathways. Mol Cell Biol. 1999;19:6742-6753.
26. Foehr ED, Lin X, O'Mahony A, et al. NF-kappaB signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells. J Neurosci. 2000;20:7556-7563.
27. Geleziunas R, Ferrell S, Lin X, et al. Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases. Mol Cell Biol. 1998;18:5157-5165.
28. Sun S, Elwood J, Greene WC. Both amino- and carboxyl-terminal sequences within IkappaB alpha regulate its inducible degradation. Mol Cell Biol. 1996;16:1058-1065.
29. Uhlik M, Good L, Xiao G, et al. NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation. J Biol Chem. 1998;273:21132-21136.
30. Delhase M, Hayakawa M, Chen Y, et al. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science. 1999;284:309-313.
31. Zhang YH, Lin JX, Vilcek J. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence. Mol Cell Biol. 1990;10:3818-3823.
32. Tomita N, Morishita R, Tomita S, et al. Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells. J Hypertens. 1998;16:993-1000.
33. Luo G, Hershko DD, Robb BW, et al. IL-1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kappaB. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1249-R1254.
34. Sparacio SM, Zhang Y, Vilcek J, et al. Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-kappa B-like nuclear protein. J Neuroimmunol. 1992;39:231-242.
35. Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappaB transcription factor. Mol Cell Biol. 1990; 10:2327-2334.
36. Vanden BW, De BK, Boone E, et al. The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem. 1999;274:32091-32098.
37. Vanden BW, Vermeulen L, De WG, et al. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem Pharmacol. 2000;60:1185-1195.
38. Matsusaka T, Fujikawa K, Nishio Y, et al. Transcription factors NF-IL6 and NF-kappaB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A. 1993;90:10193-10197.
39. Akira S, Kishimoto T. NF-IL6 and NF-kappa B in cytokine gene regulation. Adv Immunol. 1997;65:1-46.
40. Matsui H, Ihara Y, Fujio Y, et al. Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes. Cardiovasc Res. 1999;42:104-112.